mercredi 11 janvier 2017

Onco Actu du 11 janvier 2017

1. Biologie

Research finds cancer cells spread even before tumour development [Pharmafile]

2.11 Etiologie - Alimentation

Nutella maker fights back on palm oil after cancer risk study [Reuters]

3.1 Tabac

Poorer countries fail to act on smoking due to big tobacco threats, says WHO [The Guardian]

3.3 Prévention - Vaccins

HPV Vaccines Are an Underused Tool for Prevention [Cancer Research Catalyst]

Trump Team Says It Hasn't Asked RFK, Jr., To Lead Vaccine Review [Forbes]

And so the dismantling of public health begins: Donald Trump meets with antivaccine ideologue Robert F. Kennedy, Jr. to discuss “vaccine safety” and autism [Respectful Insolence]

Anti-Vaccine Activist Says Trump Wants Him to Lead Panel on Immunization Safety [NY Times]

4.1 Dép., diag. & prono. - Prostate

Prostate cancer treatment rates drop, reflecting change in screening recommendations [Michigan Medicine]

4.9 Dép., diag. & prono. - Sein

Breast screening can lead to some women having unnecessary treatment [Cancer Research UK]

Overdiagnosis of ductal carcinoma in situ: ‘the pathology equivalent of racial profiling’ [HealthNewsReview]

The Latest Study On Breast Cancer Overdiagnosis Fails To Persuade [Forbes]

5.10 Traitements - Essais

National Cancer Institute unveils new effort to speed drugs to researchers [STAT]

5.2 Pharma

Merck Receives FDA Acceptance of Supplemental Biologics License Application for KEYTRUDA® (pembrolizumab) in Combination with Chemotherapy for First-Line Treatment of Metastatic Non-Squamous Non-Small Cell Lung Cancer [Merck]

FDA accepts Merck application for lung cancer combo therapy [Reuters]

5.2.2 Pharma - Fusions & Acquisitions

Takeda Takes the Hard Road [Bloomberg]

5.4 Traitements - Economie

Global Cancer Treatment Drugs Market Research Report 2017 [ResearchnReports]

6. Lutte contre les cancers

Expert cancer meetings are under growing pressure [Cancer Research UK]

The price of doing a postdoc [Science]

6.7.1 Bioinformatique

Chinese AI company plans to mine health data faster than rivals [Nature]